Quick Takeaways
- Bain Capital Life Sciences Fund II, L.P. filed SCHEDULE 13D/A for Savara Inc. Common Stock, par value $0.001 per share (SVRA).
- Disclosed ownership: 10%.
- Date of event: 25 Mar 2025.
Quoteable Key Fact
"Bain Capital Life Sciences Fund II, L.P. disclosed 10% ownership in Savara Inc. Common Stock, par value $0.001 per share (SVRA) on 25 Mar 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Bain Capital Life Sciences Fund II, L.P. | 10% | 17,600,621 | 0 | 17,600,621 | /s/ Ricky Sun | Ricky Sun, Partner of Bain Capital Life Sciences Investors, LLC | 0001773187 |
| BCIP Life Sciences Associates, LP | 10% | 17,600,621 | 0 | 17,600,621 | /s/ Ricky Sun | Ricky Sun, Authorized Signatory of Boylston Coinvestors, LLC | 0001702921 |
| BCLS II Investco, LP | 10% | 17,600,621 | 0 | 17,600,621 | /s/ Ricky Sun | Ricky Sun, Partner of Bain Capital Life Sciences Investors, LLC | 0001818893 |